Grantham, Mayo, Van Otterloo & Co (GMO)
TBIO

Grantham, Mayo, Van Otterloo & Co (GMO)’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-39,400
Closed -$706K – 848
2020
Q2 		$706K Buy
+39,400
New +$594K 0.01% 586

Other funds holding TBIO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVA
Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s TBIO Position: Q3 2020 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2020, closing a stake of 39,400 shares — an estimated $706K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in TBIO in Q2 2020 and held it in 1 quarter. The position peaked at $706K in Q2 2020. 132 funds tracked by Wall St. Rank hold TBIO as of Q3 2020.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 39,400 Translate Bio, Inc. Common Stock shares in Q3 2020, an estimated $706K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Translate Bio, Inc. Common Stock position peaked at $706K in Q2 2020.
  • 132 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2020.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2020, filed 13 Nov 2020.